 | Up a level |
Scholten, W; Simon, O; Maremmani, C; Wells, C; Kelly, J.F; Hämmig, Robert; Radbruch, L (2017). Access to treatment with controlled medicines rationale and recommendations for neutral, precise, and respectful language. Public health, 153, pp. 147-153. Elsevier 10.1016/j.puhe.2017.08.021
Hämmig, Robert; Köhler, Wilfried; Bonorden-Kleij, Karin; Weber, Bernd; Lebentrau, Karin; Berthel, Toni; Babic-Hohnjec, Lucija; Vollmert, Christian; Höpner, Doris; Gholami, Najibulah; Verthein, Uwe; Haasen, Christian; Reimer, Jens; Ruckes, Christian (2014). Safety and tolerability of slow-release oral morphine versus methadone in the treatment of opioid dependence. Journal of substance abuse treatment, 47(4), pp. 275-281. Elsevier 10.1016/j.jsat.2014.05.012
Hämmig, Robert; Uhl, Alfred; Kuhlmann, Thomas (2014). Pro & Contra: Die aktuelle Leitliniendebatte kritisch hinterfragt. Suchttherapie, 15(3), pp. 101-103. Thieme 10.1055/s-0034-1386529
Hämmig, Robert (2014). Les hallucinogènes dans la thérapie des addictions. Dépendances(52), pp. 25-27. Addiction Suisse
Besson, Jacques; Beck, Thilo; Wiesbeck, Gerhard; Hämmig, Robert; Kuntz, André; Abid, Sami; Stohler, Rudolf (2014). Opioid maintenance therapy in Switzerland: an overview of the Swiss IMPROVE study. Swiss medical weekly, 144, w13933. EMH Schweizerischer Ärzteverlag 10.4414/smw.2014.13933
Hämmig, Robert (2014). Schadenminderung und substitutionsgestützte Behandlung. SuchtMagazin, 40(2), pp. 30-34. Infodrog
Hämmig, Robert (2014). Doppeldiagnosen: 20 Jahre Suchtdiskurs. SuchtMagazin, 40(1), pp. 8-10. Infodrog
Hämmig, Robert (2014). «Das Beste ist, Sie hören auf!» «Und das Zweitbeste?» Tabak-Schadenminderung. SuchtMagazin, 40(2), pp. 52-55. Infodrog
Hämmig, Robert (2010). Tabakkonsum: Was ist das und wie kann der Schaden gemindert werden? Suchttherapie, 11(1), pp. 24-28. Stuttgart: Thieme 10.1055/s-0030-1247547
Crettol, Séverine; Déglon, Jean-Jacques; Besson, Jacques; Croquette-Krokar, Marina; Hämmig, Robert; Gothuey, Isabelle; Monnat, Martine; Eap, Chin B (2006). ABCB1 and cytochrome P450 genotypes and phenotypes: influence on methadone plasma levels and response to treatment. Clinical pharmacology & therapeutics, 80(6), pp. 668-81. New York, N.Y.: Nature Publishing Group 10.1016/j.clpt.2006.09.012
Hämmig, Robert (2014). OR07-4E-CIGS (VAPORIZERS): A public health opportunity that will be missed? Alcohol and alcoholism, 49(Supl 1), i45. Oxford University Press 10.1093/alcalc/agu053.34
Hämmig, Robert (2014). P-52 Slow-release oral morphine (srom) as further medication in opioid subtitution treatment (ost): Results from a registration study. Alcohol and alcoholism, 49(Suppl 1), i63. Oxford University Press 10.1093/alcalc/agu054.52
